Informations générales (source: ClinicalTrials.gov)
Acute Heart Failure - COngestion Discharge Evaluation. Évaluation de la Congestion à la Sortie d'Hospitalisation Pour Insuffisance Cardiaque aiguë. (AHF-CODE)
Interventional
N/A
Central Hospital, Nancy, France (Voir sur ClinicalTrials)
juillet 2020
mai 2028
29 juin 2024
Acute heart failure (AHF) is a major public health problem, associated with a 40% risk of
death or re-hospitalisation at 3 months. This risk is significantly increased by
insufficient decongestion at the end of hospitalisation for AHF assessed by a
standardised clinical score, a natriuretic peptide dosage or by cardiac and pulmonary
ultrasound .
Adapting treatment according to lung congestion assessed by implantable devices (not
reimbursed in France) improves the prognosis. However, due to the lack of a standardised
congestion assessment, therapeutic adaptation in acute heart failure is currently
empirical. The best multimodality approach to congestion evaluation is uncertain.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHRU de Nancy - 54500 - Vandoeuvre Les Nancy - France | Nicolas GIRERD, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients hospitalised for acute heart failure.
- Patients considered clinically discharging from hospitalisation for acute heart
failure.
- Age ≥18 years
- Patients having received complete information regarding the study design and having
signed their informed consent form.
- Patient affiliated to or beneficiary of a social security scheme.
- Patients hospitalised for acute heart failure.
- Patients considered clinically discharging from hospitalisation for acute heart
failure.
- Age ≥18 years
- Patients having received complete information regarding the study design and having
signed their informed consent form.
- Patient affiliated to or beneficiary of a social security scheme.
- Comorbidity for which the life expectancy is ≤ 3 months
- Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular
filtration rate <15 ml/min/m2 at inclusion.
- History of lobectomy or pneumonectomy lung surgery
- Severe pulmonary or pleural pathology preventing reliable acquisition of lung
ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc.
- Pregnant woman, parturient or nursing mother
- Adult person subject to a legal protection measure (guardianship, curatorship,
safeguard of justice)
- Adult person who is unable to give consent
- Person deprived of liberty by a judicial or administrative decision,
- Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of
the Public Health Code.